Susceptibility genetic variants associated with early-onset colorectal cancer. Carcinogenesis. 2012;33(3):613-9.
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). International journal of oncology. 2012;40(3):625-38.
Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2012;21(1):42-5.
Tools for protein-protein interaction network analysis in cancer research. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2012;14(1):3-14.
Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families. European journal of human genetics : EJHG. 2012;20(1):91-6.
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration. The pharmacogenomics journal. 2012.
Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL. Nature medicine. 2012;18(3):436-40.